Parnassus

Tamara Alliston, PhD studies the mechanobiologic mechanisms supporting skeletal health and driving arthritis, osteoporosis, and bone fragility.

Arturo Alvarez-Buylla, PhD studies the origin, migration and functional contribution of neural stem cells born in the adult brain. He has initiated studies exploring progenitor cell transplants for the treatment of Parkinson’s disease and epilepsy.

Mark Anderson, MD, PhD is the Director of the Diabetes Center. He studies immune tolerance and the role of the thymus in type 1 diabetes and autoimmune disease.

Serine Avagyan, MD, PhD studies blood stem cell clonality and clonal hematopoiesis.

Scott Baraban, PhD studies pediatric malformation-associated epilepsies in genetic mouse models to explore how seizures develop. He also researches the potential of embryonic progenitor cells to inhibit epilepsy following transplantation.

Mitchel Berger, MD studies the correlative biology and outcome of patients with both low-grade and high-grade gliomas.

Daniel Bikle, MD, PhD studies the hormonal regulation of calcium metabolism in the formation, differentiation and repair of bone and skin tissue, as well as in skin cancer development.

Robert Blelloch, MD, PhD studies gene regulation of pluripotent stem cells, early development, and cancer.

Kelsey Collins, PhD, uses induced pluripotent stem cells, CRISPR-Cas9 genome engineering, mouse models, human tissues, and state-of-the-art multi-omic spatial approaches to define mechanisms and create therapies that have implications for aging, obesity, diabetes, and other chronic diseases.

Marco Conti, MD focuses on signal transduction required for germ cell development.